NTRP
Neurotrope Inc
Halal Rating :
Last Price
$7.07
Last updated:
Market Cap
-
7D Change
-2.48%
1 Year Change
93.7%
Company Overview
Industries
Exchange
Next Earnings Date
Based on SEC filings and available data, Neurotrope Inc was a clinical-stage biopharmaceutical company that focused on developing novel therapeutics for neurodegenerative diseases, particularly Alzheimer's disease. The company merged with Petros Pharmaceuticals in December 2020 to form Petros Pharmaceuticals (NASDAQ: PTPI).
Use of Interest
Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
Nov. 30, 2024 | $74635.0 | $1.85m | - | - | 0.00% | 0.00% |
Aug. 31, 2024 | $154498.0 | $1.62m | - | - | 0.00% | 0.00% |
May 31, 2024 | $188793.0 | $2.14m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Neurotrope Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.